Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
Condition: ALS · Sponsor: Shionogi
About this study
To evaluate and compare the efficacy of two dosing regimens of oral edaravone in subjects with amyotrophic lateral sclerosis (ALS) based on the change in ALS Functional Rating Scale- Revised (ALSFRS-R) score from baseline up to Week 48:
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (95)
| St. Joseph's Hospital and Medical Center (SJHMC) | Phoenix, Arizona, United States | — |
| HonorHealth Neurology | Scottsdale, Arizona, United States | — |
| Woodland Research Northwest | Rogers, Arkansas, United States | — |
| UCSD Medical Center | La Jolla, California, United States | — |
| Loma Linda University Health Care - Department of Neurology | Loma Linda, California, United States | — |
| University California Los Angeles Medical Center (UCLA) | Los Angeles, California, United States | — |
| University of California Irvine (UCI) Health - Women's Healthcare Center | Orange, California, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| UF Health Cancer Center | Gainesville, Florida, United States | — |
| Mayo Clinic | Jacksonville, Florida, United States | — |
| University of South Florida (USF) - Carol and Frank Morsani Center for Advanced Health Care (CAHC) | Tampa, Florida, United States | — |
| Emory University - School of Medicine | Atlanta, Georgia, United States | — |
+ 83 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04569084